October Drug Recalls
This article was originally published in The Gold Sheet
You may also be interested in...
Economically motivated adulteration, glass flakes in vials, out-of-specification transdermal patches, malodorous bottles and prefilled syringe sterility were among the more significant manufacturing quality issues leading to drug recalls in the past three months.
Delfi Diagnostics will use the new funds to expand its team of cancer researchers and machine-learning experts to validate its novel approach for early cancer detection through multiple prospective clinical trials.